Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

45.68
Delayed Data
As of Feb 24
 +0.28 / +0.62%
Today’s Change
36.76
Today|||52-Week Range
45.79
+18.93%
Year-to-Date

Today’s Trading

Previous close45.40
Today’s open45.29
Day’s range45.23 - 45.68
Volume7,608,646
Average volume (3 months)9,058,812
Market cap$78.9B
Dividend yield2.32%
Data as of 4:01pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+11.38%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+2.20%
P/E ratio64.3
Price/Sales2.73
Price/Book3.28

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.16-0.54%
NVONovo Nordisk-0.18-0.50%
LLYEli Lilly and Co+0.32+0.39%
CELGCelgene-1.23-1.03%
Data as of 4:03pm ET, 02/24/2017

Financials

Next reporting dateApril 19, 2017
EPS forecast (this quarter)$0.43
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts


Search for Jobs